186 related articles for article (PubMed ID: 23555730)
1. Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice.
Carty N; Nash KR; Brownlow M; Cruite D; Wilcock D; Selenica ML; Lee DC; Gordon MN; Morgan D
PLoS One; 2013; 8(3):e59626. PubMed ID: 23555730
[TBL] [Abstract][Full Text] [Related]
2. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
[TBL] [Abstract][Full Text] [Related]
3. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP + PS1 transgenic mice.
Carty NC; Nash K; Lee D; Mercer M; Gottschall PE; Meyers C; Muzyczka N; Gordon MN; Morgan D
Mol Ther; 2008 Sep; 16(9):1580-6. PubMed ID: 18665160
[TBL] [Abstract][Full Text] [Related]
5. CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes.
Jiang H; Niu F; Zheng Y; Xu Y
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604684
[TBL] [Abstract][Full Text] [Related]
6. Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain.
Wang S; Wang R; Chen L; Bennett DA; Dickson DW; Wang DS
J Neurochem; 2010 Oct; 115(1):47-57. PubMed ID: 20663017
[TBL] [Abstract][Full Text] [Related]
7. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
[TBL] [Abstract][Full Text] [Related]
8. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
9. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
10. Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation.
Gallagher JJ; Minogue AM; Lynch MA
Neurodegener Dis; 2013; 11(1):33-41. PubMed ID: 22627185
[TBL] [Abstract][Full Text] [Related]
11. Effect of Global Brain Ischemia on Amyloid Precursor Protein Metabolism and Expression of Amyloid-Degrading Enzymes in Rat Cortex: Role in Pathogenesis of Alzheimer's Disease.
Babusikova E; Dobrota D; Turner AJ; Nalivaeva NN
Biochemistry (Mosc); 2021 Jun; 86(6):680-692. PubMed ID: 34225591
[TBL] [Abstract][Full Text] [Related]
12. Activating AhR alleviates cognitive deficits of Alzheimer's disease model mice by upregulating endogenous Aβ catabolic enzyme Neprilysin.
Qian C; Yang C; Lu M; Bao J; Shen H; Deng B; Li S; Li W; Zhang M; Cao C
Theranostics; 2021; 11(18):8797-8812. PubMed ID: 34522212
[No Abstract] [Full Text] [Related]
13. Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress.
de Dios C; Bartolessis I; Roca-Agujetas V; Barbero-Camps E; Mari M; Morales A; Colell A
Redox Biol; 2019 Sep; 26():101283. PubMed ID: 31376793
[TBL] [Abstract][Full Text] [Related]
14. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.
Marr RA; Rockenstein E; Mukherjee A; Kindy MS; Hersh LB; Gage FH; Verma IM; Masliah E
J Neurosci; 2003 Mar; 23(6):1992-6. PubMed ID: 12657655
[TBL] [Abstract][Full Text] [Related]
15. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
Yang H; Yang H; Xie Z; Wang P; Bi J
Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263
[TBL] [Abstract][Full Text] [Related]
16. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease.
Yang W; Chauhan A; Wegiel J; Kuchna I; Gu F; Chauhan V
Curr Alzheimer Res; 2014; 11(10):1002-11. PubMed ID: 25387339
[TBL] [Abstract][Full Text] [Related]
17. Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease.
Dorfman VB; Pasquini L; Riudavets M; López-Costa JJ; Villegas A; Troncoso JC; Lopera F; Castaño EM; Morelli L
Neurobiol Aging; 2010 Oct; 31(10):1743-57. PubMed ID: 19019493
[TBL] [Abstract][Full Text] [Related]
18. p75NTR regulates Abeta deposition by increasing Abeta production but inhibiting Abeta aggregation with its extracellular domain.
Wang YJ; Wang X; Lu JJ; Li QX; Gao CY; Liu XH; Sun Y; Yang M; Lim Y; Evin G; Zhong JH; Masters C; Zhou XF
J Neurosci; 2011 Feb; 31(6):2292-304. PubMed ID: 21307265
[TBL] [Abstract][Full Text] [Related]
19. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death.
Leissring MA; Farris W; Chang AY; Walsh DM; Wu X; Sun X; Frosch MP; Selkoe DJ
Neuron; 2003 Dec; 40(6):1087-93. PubMed ID: 14687544
[TBL] [Abstract][Full Text] [Related]
20. Transition from an M1 to a mixed neuroinflammatory phenotype increases amyloid deposition in APP/PS1 transgenic mice.
Weekman EM; Sudduth TL; Abner EL; Popa GJ; Mendenhall MD; Brothers HM; Braun K; Greenstein A; Wilcock DM
J Neuroinflammation; 2014 Jul; 11():127. PubMed ID: 25062954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
